Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy Subjects

Exclusion Criteria

• •1. A history of recurrent or severe drug food allergy, or known or suspected allergy to any component of the study drug.
• •2. Have a history of hypertension.
• •3. Severe systemic infectious diseases within 1 month before screening.
• •4. Use of prescription drugs (topical eye/nasal drops and creams and occasional antipyretic and analgesic drugs such as acetaminophen within recommended doses are permitted) and over-the-counter drugs, and Chinese herbal medicine (regular vitamins are allowed) within 2 weeks before screening.
• •5. Presence of any abnormal and clinically significant laboratory tests.
• •6. 12-lead electrocardiogram (ECG) showed abnormal and clinically significant.
• •7. Known or suspected history of drug abuse or positive urine drug screening test within screening period.
• •8. Those who have participated in any drug clinical trials within 3 months or 5 half-life periods before screening (The elder shall prevail), who participated in clinical trials are defined as random, prior to screening;
• •9. Women who are pregnant, breastfeeding or planning to conceive, or women of childbearing potential (WOCBP) are reluctant to use appropriate contraception during the trial.